We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Uranium Energy
UEC
$5.57B
| $761K | ﹤0.01% |
249,626
+38,414
| +18% | +$96.3K |
|
2352
Oric Pharmaceuticals
ORIC
$1.4B
| $760K | ﹤0.01% |
36,352
+2,578
| +8% | +$52.3K |
|
|
CATC
2353
DELISTED
CAMBRIDGE BANCORP
CATC
| $760K | ﹤0.01% |
8,635
+235
| +3% | +$19.8K |
|
2354
Ennis
EBF
$564M
| $758K | ﹤0.01% |
40,205
-21,300
| -35% | -$418K |
|
2355
Protagonist Therapeutics
PTGX
$9.44B
| $757K | ﹤0.01% |
42,695
+1,883
| +5% | +$80.3K |
|
2356
FIGS
FIGS
$2.37B
| $755K | ﹤0.01% |
+20,320
| New | +$819K |
|
2357
Park Aerospace
PKE
$819M
| $750K | ﹤0.01% |
54,833
-43,562
| -44% | -$639K |
|
2358
Tidewater
TDW
$4.12B
| $750K | ﹤0.01% |
62,228
+2,020
| +3% | +$23K |
|
2359
Lennar Class B
LEN.B
$20.8B
| $749K | ﹤0.01% |
10,154
-252
| -2% | -$20.1K |
|
2360
Titan Machinery
TITN
$445M
| $748K | ﹤0.01% |
28,858
+900
| +3% | +$25.3K |
|
2361
Waterstone Financial
WSBF
$375M
| $747K | ﹤0.01% |
36,476
+1,000
| +3% | +$19.9K |
|
2362
Crinetics Pharmaceuticals
CRNX
$8.92B
| $745K | ﹤0.01% |
35,403
+1,852
| +6% | +$38.7K |
|
|
SGFY
2363
DELISTED
Signify Health, Inc.
SGFY
| $743K | ﹤0.01% |
41,591
+21,150
| +103% | +$544K |
|
2364
Phillips Edison & Co
PECO
$5.24B
| $741K | ﹤0.01% |
+24,116
| New | +$708K |
|
2365
Alpha and Omega Semiconductor
AOSL
$1.08B
| $739K | ﹤0.01% |
23,545
+950
| +4% | +$26.3K |
|
2366
PMV Pharmaceuticals
PMVP
$63.5M
| $739K | ﹤0.01% |
24,811
+1,257
| +5% | +$40.1K |
|
2367
CarParts.com
PRTS
$54.7M
| $738K | ﹤0.01% |
4,726
+230
| +5% | +$40K |
|
|
THR
2368
DELISTED
Thermon Group Holdings
THR
| $737K | ﹤0.01% |
42,554
+1,550
| +4% | +$25.8K |
|
|
FLIC
2369
DELISTED
First of Long Island Corp
FLIC
| $733K | ﹤0.01% |
35,564
+965
| +3% | +$20.3K |
|
|
DMTK
2370
DELISTED
DermTech, Inc. Common Stock
DMTK
| $733K | ﹤0.01% |
22,827
-5
| -0% | -$176 |
|
|
AEVA
2371
Aeva Technologies
AEVA
$1.86B
| $731K | ﹤0.01% |
18,423
+12,702
| +222% | +$591K |
|
2372
Olema Pharmaceuticals
OLMA
$1.05B
| $731K | ﹤0.01% |
26,507
+13,373
| +102% | +$361K |
|
2373
iShares Russell Mid-Cap Value ETF
IWS
$16B
| $728K | ﹤0.01% |
6,431
+4,322
| +205% | +$500K |
|
|
STEL
2374
DELISTED
Stellar Bancorp
STEL
| $728K | ﹤0.01% |
27,597
+875
| +3% | +$23.2K |
|
2375
Vishay Precision Group
VPG
$914M
| $727K | ﹤0.01% |
20,914
+575
| +3% | +$20.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.